It’s time to take psilocybin seriously as a possible treatment for substance use disorders
The American Journal of Drug and Alcohol Abuse August 24, 2016 DOI: 10.1080/00952990.2016.1200060 via OpenAlex
Summary
AI-generated from the abstractA pilot study testing a treatment model that uses 2–3 doses of psilocybin for smoking cessation provides long-term outcome data. The results suggest the intervention may help maintain abstinence over an extended period, though the small sample size and lack of a control group limit the strength of the conclusions.
Study at a glance
| Characteristics | Pilot study Peer reviewed |
|---|---|
| Intervention | Psilocybin |
| Dose | 2–3 doses |
| Duration | 12-month follow-up |
| Topics | Psilocybin |
| Keywords | Psychiatry Substance use Substance abuse treatment Psychology |
| Citations | 18 |
| Key finding | The treatment model using 2–3 doses of psilocybin may support long-term smoking cessation, but the evidence is preliminary due to the pilot design. |
Abstract
In the current issue of the American Journal of Drug and Alcohol Abuse, Johnson et al. (1) provide long-term outcome data from a smoking cessation pilot study of a treatment model using 2–3 doses o...